Angioedema - 90 Studies Found

Active, not recruiting : Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2015-10-20
: Drug: C1 esterase inhibitor [human] liquid C1 Esterase Inhibitor [Human] Liquid administered Subcutaneou
Terminated : Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema
:
  • Hereditary Angioedema
  • HAE

: 2016-01-20
: Drug: avoralstat Other Name: BCX4161
Active, not recruiting : A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
: Hereditary Angioedema Types I and II
: 2014-12-10
: Biological: C1-esterase inhibitor
Completed : Biomarker for Hereditary Angioedema Disease Type 1
:
  • Hereditary AngioEdema
  • Angioedema, Heredit
    : 2017-01-18
Completed : C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)
: Hereditary Angioedema
: 2006-02-15
: Drug: C1 Esterase Inhibitor Lyophilisate containing approximately 500 U C1-INH to be reconstituted with
Completed : Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
: Hereditary Angioedema
: 2005-09-12
:
  • Biological: C1 Esterase Inhibitor

Completed : C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
: Hereditary Angioedema
: 2006-02-07
:
  • Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed : A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor
: Hereditary Angioedema Types I and II
: 2012-12-24
:
  • Biological: Berinert Berinert

Completed : A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
: Hereditary Angioedema Types I and II
: 2012-04-10
:
  • Biological: C1-esterase inhibitor - single intravenous dose

Completed : Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
: Hereditary Angioedema Types I and II
: 2011-11-07
: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection
<<< Previous | Next >>>